Halvorson D J, McKie V, McKie K, Ashmore P E, Porubsky E S
Department of Surgery, Medical College of Georgia, Augusta, USA.
Arch Otolaryngol Head Neck Surg. 1997 Jul;123(7):689-92. doi: 10.1001/archotol.1997.01900070033005.
Patients with sickle cell disease are recognized as having a relatively higher risk for postoperative complications, including fever, atelectasis, pneumonia, or sickle cell vas-occlusion.
To present a protocol for preoperative management of patients with sickle cell disease undergoing tonsillectomy, including the use of transfusions and intravenous hydration.
Retrospective chart review.
Academic, tertiary care referral medical center.
Seventy-five patients with sickle cell disease who underwent tonsillectomy with or without adenoidectomy were included for review. Preoperative management was documented, and risk factors were assessed. Intraoperative management was reviewed, and postoperative complications were identified and compared with preoperative data and management.
Preoperative management consisted of transfusions to a hemoglobin S ratio (hemoglobin S-total hemoglobin) less than 40% or a hemoglobin level greater than 100 g/L. Aggressive intravenous hydration of 1.5 times the maintenance fluid was given 24 hours before surgery. Increased complications were associated with a preoperative hemoglobin S ratio greater than 40% (P < .05) and an age younger than 4 years (P < .05). Operative time, technique, and blood loss were not statistically significant risk factors. The average length of hospitalization was 4.8 days.
Children with sickle cell disease presenting for elective tonsillectomy should be given a transfusion to a hemoglobin S ratio less than 40% in an attempt to reduce postoperative complications. Additional factors, such as age and presence of obstructive sleep apnea, only increase the potential risks.
镰状细胞病患者被认为术后并发症风险相对较高,包括发热、肺不张、肺炎或镰状细胞血管阻塞。
提出镰状细胞病患者行扁桃体切除术的术前管理方案,包括输血和静脉补液的使用。
回顾性病历审查。
学术性三级医疗转诊中心。
纳入75例行扁桃体切除术(伴或不伴腺样体切除术)的镰状细胞病患者进行审查。记录术前管理情况并评估风险因素。回顾术中管理情况,识别术后并发症并与术前数据和管理情况进行比较。
术前管理包括输血使血红蛋白S比例(血红蛋白S-总血红蛋白)低于40%或血红蛋白水平高于100 g/L。术前24小时给予维持液量1.5倍的积极静脉补液。术前血红蛋白S比例大于40%(P < 0.05)和年龄小于4岁(P < 0.05)与并发症增加相关。手术时间、技术和失血量不是统计学上的显著风险因素。平均住院时间为4.8天。
拟行择期扁桃体切除术的镰状细胞病患儿应输血使血红蛋白S比例低于40%,以降低术后并发症。其他因素,如年龄和阻塞性睡眠呼吸暂停的存在,只会增加潜在风险。